These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19330798)

  • 1. Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells.
    Soni S; Lin BT; August A; Nicholson RI; Kirsch KH
    J Cell Biochem; 2009 May; 107(2):364-75. PubMed ID: 19330798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2.
    Kumbrink J; Kirsch KH
    Neoplasia; 2012 Feb; 14(2):108-20. PubMed ID: 22431919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
    Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC
    Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b.
    Riggins RB; Thomas KS; Ta HQ; Wen J; Davis RJ; Schuh NR; Donelan SS; Owen KA; Gibson MA; Shupnik MA; Silva CM; Parsons SJ; Clarke R; Bouton AH
    Cancer Res; 2006 Jul; 66(14):7007-15. PubMed ID: 16849545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling.
    Schrecengost RS; Riggins RB; Thomas KS; Guerrero MS; Bouton AH
    Cancer Res; 2007 Jul; 67(13):6174-82. PubMed ID: 17616674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines.
    van Agthoven T; Godinho MF; Wulfkuhle JD; Petricoin EF; Dorssers LC
    Int J Cancer; 2012 Nov; 131(9):1998-2007. PubMed ID: 22328489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells.
    Ta HQ; Thomas KS; Schrecengost RS; Bouton AH
    Cancer Res; 2008 Nov; 68(21):8796-804. PubMed ID: 18974122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer anti-estrogen resistance 3 (BCAR3) protein augments binding of the c-Src SH3 domain to Crk-associated substrate (p130cas).
    Makkinje A; Vanden Borre P; Near RI; Patel PS; Lerner A
    J Biol Chem; 2012 Aug; 287(33):27703-14. PubMed ID: 22711540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Novel Crk-associated Substrate (p130Cas) Variants with Functionally Distinct Focal Adhesion Kinase Binding Activities.
    Kumbrink J; Soni S; Laumbacher B; Loesch B; Kirsch KH
    J Biol Chem; 2015 May; 290(19):12247-55. PubMed ID: 25805500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
    Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H
    J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance.
    Thomas NB; Hutcheson IR; Campbell L; Gee J; Taylor KM; Nicholson RI; Gumbleton M
    Breast Cancer Res Treat; 2010 Feb; 119(3):575-91. PubMed ID: 19288272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes.
    Zhang Y; Moerkens M; Ramaiahgari S; de Bont H; Price L; Meerman J; van de Water B
    Breast Cancer Res; 2011 May; 13(3):R52. PubMed ID: 21595894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin ligase c-Cbl is involved in tamoxifen-induced apoptosis of MCF-7 cells by downregulating the survival signals.
    Yan SC; Liu YP; Zhang LY; Qu JL; Xu L; Liu J; Zhang Y; Hou KZ; Teng YE; Qu XJ
    Acta Oncol; 2011 Jun; 50(5):693-9. PubMed ID: 21175263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells.
    Brinkman A; van der Flier S; Kok EM; Dorssers LC
    J Natl Cancer Inst; 2000 Jan; 92(2):112-20. PubMed ID: 10639512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ack1 mediates Cdc42-dependent cell migration and signaling to p130Cas.
    Modzelewska K; Newman LP; Desai R; Keely PJ
    J Biol Chem; 2006 Dec; 281(49):37527-35. PubMed ID: 17038317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2.
    Pancholi S; Lykkesfeldt AE; Hilmi C; Banerjee S; Leary A; Drury S; Johnston S; Dowsett M; Martin LA
    Endocr Relat Cancer; 2008 Dec; 15(4):985-1002. PubMed ID: 18824559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
    Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
    Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells.
    Godinho M; Meijer D; Setyono-Han B; Dorssers LC; van Agthoven T
    J Cell Physiol; 2011 Jul; 226(7):1741-9. PubMed ID: 21506106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of Evn-50 on cell growth and apoptosis in tamoxifen-resistance human breast cancer cell line MCF-7/TAM-R].
    Hu HY; Zhou J; Wan F; Dong LF; Zhang F; Wang YK; Chen FF; Chen YD
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):498-505. PubMed ID: 23086641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.